Oliver Blanck studied computer science with a focus on Stereotactic Radiotherapy treatment planning until 2008 and received a PhD for his preclinical work on Stereotactic Arrythmia Radioablation (STAR) in 2013, both at the University of Lübeck, and habilitated in Medical Physics in 2024 at the Christian-Albrechts-University of Kiel. Currently, he is the chief officer of operations and head medical physics, research, and development at the Saphir Radiosurgery centers in Frankfurt and Kiel and the research coordinator of multiple clinical trials on Stereotactic Radiotherapy at the department of radiation oncology of the University Medical Center Schleswig-Holstein in Kiel. Furthermore, Oliver Blanck is an active and awarded member of several scientific societies as well as a board member of the working groups for Stereotactic Radiotherapy of the German Radiation Oncology and Medical Physics Societies and the lead coordinator of the EU-Horizon-2020 STOPSTORM consortium project on STAR.